These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Natural killer/T-cell nasal-type lymphoma: unusual primary spinal tumor. Yang C; Ma J; Yang X; Jia L; Liu H; Xiao J Spine (Phila Pa 1976); 2008 Nov; 33(24):E929-32. PubMed ID: 19011534 [TBL] [Abstract][Full Text] [Related]
26. Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas. Niitsu N; Okamoto M; Nakamine H; Aoki S; Motomura S; Hirano M Hematol Oncol; 2008 Sep; 26(3):152-8. PubMed ID: 18395866 [TBL] [Abstract][Full Text] [Related]
27. [Non-Hodgkin's lymphomas of the skin]. Sretenović M; Milivojević G; Donfrid M; Petrović Z; Nedeljkov-Janić R; Milojević M; Jovanović V; Bosković D; Petrović M Srp Arh Celok Lek; 1994; 122(3-4):75-8. PubMed ID: 17972814 [TBL] [Abstract][Full Text] [Related]
28. Novel treatment avenues for peripheral T-cell lymphomas. Hopfinger G; Griessl R; Sifft E; Taylor N; Kenner L; Greil R; Merkel O Expert Opin Drug Discov; 2012 Dec; 7(12):1149-63. PubMed ID: 22998641 [TBL] [Abstract][Full Text] [Related]
29. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma. Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938 [TBL] [Abstract][Full Text] [Related]
30. Update on treatment of cutaneous T-cell lymphoma. Gardner JM; Evans KG; Musiek A; Rook AH; Kim EJ Curr Opin Oncol; 2009 Mar; 21(2):131-7. PubMed ID: 19532014 [TBL] [Abstract][Full Text] [Related]
31. [Clinical characteristics and prognostic factors in 73 patients with peripheral T cell lymphoma]. Huang XC; Li XL; Huang RX; Jin XS Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 33(2):151-5. PubMed ID: 18326910 [TBL] [Abstract][Full Text] [Related]
32. Histopathology of Hodgkin's lymphoma. Eberle FC; Mani H; Jaffe ES Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308 [TBL] [Abstract][Full Text] [Related]
34. [Peripheral T cell lymphoma]. Niitsu N Gan To Kagaku Ryoho; 2009 May; 36(5):752-5. PubMed ID: 19496284 [No Abstract] [Full Text] [Related]
35. Allogeneic transplantation in lymphoma: current status. Schmitz N; Dreger P; Glass B; Sureda A Haematologica; 2007 Nov; 92(11):1533-48. PubMed ID: 18024402 [TBL] [Abstract][Full Text] [Related]
36. Hepatitis C and lymphoproliferative disorders: from mixed cryoglobulinemia to non-Hodgkin's lymphoma. Martyak LA; Yeganeh M; Saab S Clin Gastroenterol Hepatol; 2009 Aug; 7(8):900-5. PubMed ID: 19362606 [TBL] [Abstract][Full Text] [Related]
37. Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma. Vranovsky A; Ladicka M; Lakota J Neoplasma; 2008; 55(2):107-12. PubMed ID: 18652043 [TBL] [Abstract][Full Text] [Related]
38. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas. Piccaluga PP; Califano A; Klein U; Agostinelli C; Bellosillo B; Gimeno E; Serrano S; Solè F; Zang Y; Falini B; Zinzani PL; Pileri SA Haematologica; 2008 Jul; 93(7):1033-8. PubMed ID: 18492688 [TBL] [Abstract][Full Text] [Related]